Philippe Chambon

Director at Stilla Technologies

Philippe joined the Digital Health venture team of LBO France as a Venture Partner in early 2018 after a distinguished career in healthcare venture capital in the US. He is also part time CEO of a couple biopharmaceutical startups. He started his business career in 1987 in the pharmaceutical industry, with Sandoz Pharmaceutical US affiliate and in 1993 he joined The Boston Consulting Group as a Manager. He has made numerous marquis name investments in the digital health sector over the years (such as ePocrates, Spotfire and Truveris) as part of his broader investments activities, first at The Sprout group which he joined in 1995, and then with New Leaf Venture Partners. In his role of Managing Director he led the spin-off of NLV from Sprout in 2005 and then the fundraising effort of 4 funds totaling over $1billion.

He has investment and board experience across all stage of growth of companies, from start up to public and small buy-outs.

Philippe earned an MDPhD degree from University Paris V and an MBA from Columbia University. He is currently a board member of several private companies in France and the US.

Links

Timeline

  • Director

    Current role